Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription 01.04.2024 1 Arch Virol 1 Biochem Biophys Res Commun 1 BMC Pediatr 2 BMJ 1 J Virol 4 JAMA 3 Lancet 1 MMWR Morb Mortal Wkly Rep 1 PLoS Comput Biol 22 PLoS One 4 Vaccine 2 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. LI X, Ding G, Li S, Liu C, et al
   Proteomic characteristics of the treatment trajectory of patients with COVID-19.
   Arch Virol. 2024;169:84.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. HE K, Ye Y, Liu S, Yuan P, et al
   Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus.
   Biochem Biophys Res Commun. 2024;709:149821.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. TANG CM, Kuo CY, Yen CW, Lin JJ, et al
   Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study.
   BMC Pediatr. 2024;24:211.
   PubMed         Abstract available
   
   

   
   BMJ

4. MAHASE E
   Covid-19: Pfizer vaccine to be available privately at pharmacy chain Boots from April.
   BMJ. 2024;384:q762.
   PubMed        
   
   
5. SHEPHERD A
   Covid remembered in NHS portraits.
   BMJ. 2024;384:q741.
   PubMed        
   
   

   
   J Virol

6. BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
   Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
   J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
   PubMed         Abstract available
   
   

   
   JAMA

7. HARRIS E
   Better Outcomes When Kidney Damage Is From COVID-19.
   JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
   PubMed        
   
   
8. HARRIS E
   HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
   JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
   PubMed        
   
   
9. HARRIS E
   CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
   JAMA. 2024;331:907.
   PubMed        
   
   
10. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    PubMed        
    
    

    
    Lancet

11. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    PubMed         Abstract available
    
    
12. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    PubMed        
    
    
13. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

14. WILLIAMS SL, Smith DJ, Benedict K, Ahlers JR, et al
    Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:239-244.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

15. HASSE T, Mantei E, Shahoei R, Pawnikar S, et al
    Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein.
    PLoS Comput Biol. 2024;20:e1011955.
    PubMed         Abstract available
    
    

    
    PLoS One

16. SCHUMACHER A, Micheli L
    Anticipated scarcity and stockpiling during the COVID-19 pandemic: The role of perceived threat, childhood SES and materialism.
    PLoS One. 2024;19:e0294497.
    PubMed         Abstract available
    
    
17. ABUGATTAS-NUNEZ DEL PRADO J, Quintana Reyes A, Leon J, Blume La Torre J, et al
    Clinical validation of RCSMS: A rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva.
    PLoS One. 2024;19:e0290466.
    PubMed         Abstract available
    
    
18. TIRUNEH GT, Fesseha N, Emaway D, Betemariam W, et al
    Effect of community-based newborn care implementation strategies on access to and effective coverage of possible serious bacterial infection (PSBI) treatment for sick young infants during COVID-19 pandemic.
    PLoS One. 2024;19:e0300880.
    PubMed         Abstract available
    
    
19. AHMAD T, Ibrahim M, Naz O, Abdullah M, et al
    Optimizing immunization services: A Data Envelopment Analysis (DEA) of child immunization facilities in Pakistan.
    PLoS One. 2024;19:e0298308.
    PubMed         Abstract available
    
    
20. GHEIDARI D, Mehrdad M, Bayat M
    Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors.
    PLoS One. 2024;19:e0299301.
    PubMed         Abstract available
    
    
21. WAN PUTEH SE, Aazmi MS, Aziz MN, Kamarudin N', et al
    Cross-sectional study of influenza trends and costs in Malaysia between 2016 and 2018.
    PLoS One. 2024;19:e0301068.
    PubMed         Abstract available
    
    
22. TAILLANDIER P, Chapuis K, Gaudou B, Brugiere A, et al
    COMOKIT v2: A multi-scale approach to modeling and simulating epidemic control policies.
    PLoS One. 2024;19:e0299626.
    PubMed         Abstract available
    
    
23. THIEULENT CJ, Carossino M, Peak L, Wolfson W, et al
    Development and validation of multiplex one-step qPCR/RT-qPCR assays for simultaneous detection of SARS-CoV-2 and pathogens associated with feline respiratory disease complex.
    PLoS One. 2024;19:e0297796.
    PubMed         Abstract available
    
    
24. ZHAO L, Ferraro P, Shorten R
    A smart mask to enforce social contracts based on IOTA Tangle.
    PLoS One. 2024;19:e0292850.
    PubMed         Abstract available
    
    
25. TOWNSLEY H, Gahir J, Russell TW, Greenwood D, et al
    COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
    PLoS One. 2024;19:e0294897.
    PubMed         Abstract available
    
    
26. ADAMCZYK G
    Pathological buying on the rise? Compensative and compulsive buying in Poland in the pre- and (Post-)pandemic times.
    PLoS One. 2024;19:e0298856.
    PubMed         Abstract available
    
    
27. GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
    Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination.
    PLoS One. 2024;19:e0298272.
    PubMed         Abstract available
    
    
28. GEORGE JF
    Discovering why people believe disinformation about healthcare.
    PLoS One. 2024;19:e0300497.
    PubMed         Abstract available
    
    
29. ZHOU R, Johnson KE, Rousseau JF, Rathouz PJ, et al
    Comparative effectiveness of dexamethasone in treatment of hospitalized COVID-19 patients in the United States during the first year of the pandemic: Findings from the National COVID Cohort Collaborative (N3C) data repository.
    PLoS One. 2024;19:e0294892.
    PubMed         Abstract available
    
    
30. NAGASAWA S, Hirata Y, Miyamoto S, Ozono S, et al
    Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.
    PLoS One. 2024;19:e0287068.
    PubMed         Abstract available
    
    
31. DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
    Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
    PLoS One. 2024;19:e0301056.
    PubMed         Abstract available
    
    
32. KOMORI A, Mori H, Xie W, Valenti S, et al
    Rapid resurgence of syphilis in Japan after the COVID-19 pandemic: A descriptive study.
    PLoS One. 2024;19:e0298288.
    PubMed         Abstract available
    
    
33. RENZI E, Baccolini V, Covelli A, Siena LM, et al
    Keeping university open did not increase the risk of SARS-CoV-2 acquisition: A test negative case-control study among students.
    PLoS One. 2024;19:e0301215.
    PubMed         Abstract available
    
    
34. CANGUSSU LR, Do Nascimento JAS, de Barros IRP, Cavalcanti RL, et al
    Effects of primary health care and socioeconomic aspects on the dispersion of COVID-19 in the Brazilian Northeast: Ecological study of the first pandemic wave.
    PLoS One. 2024;19:e0296837.
    PubMed         Abstract available
    
    
35. BRAY LA, Jervis LL, Janitz AE, Ross L, et al
    Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.
    PLoS One. 2024;19:e0300872.
    PubMed         Abstract available
    
    
36. XUE J, Zhou X, Yang J, Niu A, et al
    Comparative study on differential expression analysis methods for single-cell RNA sequencing data with small biological replicates: Based on single-cell transcriptional data of PBMCs from COVID-19 severe patients.
    PLoS One. 2024;19:e0299358.
    PubMed         Abstract available
    
    
37. BLAKE L, Tucker P, Vanderloo LM
    Mothers' perspectives of the barriers and facilitators to reducing young children's screen time during COVID-19: A reddit content analysis.
    PLoS One. 2024;19:e0301089.
    PubMed         Abstract available
    
    

    
    Vaccine

38. KLUWER B, Gleditsch R, Rydland KM, Mamelund SE, et al
    Higher educational attainment associated with higher confidence in influenza vaccination in Norway.
    Vaccine. 2024 Mar 21:S0264-410X(24)00338-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
39. VOLKMANN AM, Goldin S, McMurren B, Gapare C, et al
    Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: A global qualitative analysis.
    Vaccine. 2024 Mar 25:S0264-410X(23)01490-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
40. BIEGUS J, Szenborn L, Zymlinski R, Zakliczynski M, et al
    The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure.
    Vaccine. 2024 Mar 25:S0264-410X(24)00366-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
41. DALEY MF, Reifler LM, Shoup JA, Glanz JM, et al
    Influenza vaccination accuracy among adults: Self-report compared with electronic health record data.
    Vaccine. 2024 Mar 25:S0264-410X(24)00339-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virus Res

42. KUZIKOV M, Reinshagen J, Wycisk K, Corona A, et al
    Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Virus Res. 2024;343:199356.
    PubMed         Abstract available
    
    
43. GLENET M, Lebreil AL, N'Guyen Y, Meyer I, et al
    Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.
    Virus Res. 2024;343:199354.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.